Bank Julius Baer & Co. Ltd, Zurich Gilead Sciences, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$23.9 Billion
Q2 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 686,205 shares of GILD stock, worth $57.4 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

686,205

Previous 704,309 2.57%

Holding current value

$57.4 Million

Previous $51.6 Million 8.74%

% of portfolio

0.2%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $1.14 Million - $1.32 Million	-18,104 Reduced 2.57%	686,205 $47.1 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $19.6 Million - $24 Million	274,373 Added 63.82%	704,309 $51.6 Million
Q4 2023 May 16, 2024	BUY	$73.27 - $83.09 $12.1 Million - $13.7 Million	164,492 Added 61.97%	429,936 $34.8 Million
Q4 2023 May 16, 2024	SELL	$73.27 - $83.09 $32.2 Million - $36.5 Million	-438,865 Reduced 62.31%	265,444 $21.5 Million
Q4 2023 Feb 02, 2024	BUY	$73.27 - $83.09 $924,447 - $1.05 Million	12,617 Added 3.02%	429,936 $34.8 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.72 Million - $1.88 Million	23,313 Added 5.92%	417,319 $31.3 Million
Q2 2023 Jul 24, 2023	BUY	$76.01 - $86.7 $29.9 Million - $34.2 Million	394,006 New	394,006 $30.4 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $2.41 Million - $2.74 Million	31,129 Added 8.48%	398,398 $33.1 Million
Q4 2022 Jan 24, 2023	BUY	$62.32 - $89.47 $113,858 - $163,461	1,827 Added 0.5%	367,269 $31.5 Million
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $109,017 - $124,526	1,831 Added 0.5%	365,442 $22.5 Million
Q2 2022 Jul 22, 2022	BUY	$57.72 - $65.01 $705,453 - $794,552	12,222 Added 3.48%	363,611 $22.5 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $296,029 - $370,956	5,111 Added 1.48%	351,389 $20.9 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $24,135 - $27,394	-372 Reduced 0.11%	346,278 $25.1 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $1.23 Million - $1.33 Million	-18,177 Reduced 4.98%	346,650 $24.2 Million
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $1.11 Million - $1.22 Million	17,540 Added 5.05%	364,827 $25.1 Million
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $511,920 - $584,100	-8,532 Reduced 2.4%	347,287 $22.4 Million
Q4 2020 Feb 24, 2021	BUY	$56.65 - $64.55 $2.91 Million - $3.32 Million	51,410 Added 16.89%	355,819 $20.7 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $4.64 Million - $5.28 Million	-81,819 Reduced 21.18%	304,409 $20.7 Million
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $4.5 Million - $5.66 Million	-72,455 Reduced 15.8%	386,228 $24.4 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $26.3 Million - $30.6 Million	-363,864 Reduced 44.24%	458,683 $35.3 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $51.5 Million - $66 Million	822,547 New	822,547 $61.5 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account

Bank Julius Baer & Co. Ltd, Zurich Gilead Sciences, Inc. Transaction History